Intellectual property is still seen as a “dirty term” in the EU, the assistant general counsel of pharmaceutical company GlaxoSmithKline has claimed.
If you have already subscribed please login.
If you have any technical issues please email tech support.
GSK, Harley Davidson, counterfeits, ACTA, WCO, OHIM, GlaxoSmithKline, Sarah Jeffery
